Cytokinetics (CYTK) EVP Malik Fady Ibraham Exercises Options, Sells 3,500 Shares

What Happened

• Malik Fady Ibraham, EVP Research & Development at Cytokinetics (CYTK), exercised 3,500 options at a $7.80 strike (cost $27,300) and sold 3,500 shares in an open-market transaction for $75.46 each, generating $264,110. The filing also records a derivative conversion/disposition for 3,500 shares at $0.00 on the same date.

Key Details

• Transaction date: 2026-09-08
• Exercise (code M, Acquired): 3,500 shares @ $7.80 = $27,300
• Sale (code S, Disposed): 3,500 shares @ $75.46 = $264,110
• Derivative conversion/disposition (code M, Disposed): 3,500 shares @ $0.00 (listed in filing)
• Shares owned after transaction: not specified in the filing
• Filing timeliness: reported and filed with the SEC on 2026-09-08 (same day)

Context

• Because the exercised shares were sold the same day, this appears to be a cashless-style exercise (options converted and then shares sold). The $0.00 derivative line is a filing entry commonly used when a derivative is converted to underlying shares; the form does not assign additional monetary value for that line. These transactions are routine insider liquidity actions and do not by themselves indicate company outlook.